Loading…
Neochem Bio Solutions (NEOCHEM)₹104.600.00%Specialty Chemicals
In the Mar 2026 quarter (standalone), Neochem Bio Solutions reported sales of ₹64.76 Cr, up 38.4% from Mar 2025, and net profit of ₹7.03 Cr, up 16.8% year on year. For the year to Mar 2026, sales were ₹111 Cr and net profit ₹12.05 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales | 46.80 | 64.76 |
| Expenses | 38.91 | 53.89 |
| Operating Profit | 7.99 | 10.99 |
| OPM % | 17.1% | 17.0% |
| Other Income | 1.99 | 0.99 |
| Interest | 2.01 | 2.01 |
| Depreciation | 0.99 | 0.99 |
| Profit before tax | 7.01 | 9.99 |
| Tax % | 24.0% | 30.1% |
| Exceptional items | 0.00 | −0.42 |
| Net Profit | 6.02 | 7.03 |
| EPS (Rs) | 8.30 | 4.00 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 48.80 | 47.85 | 60.73 | 83.65 | 111 |
| Expenses | 44.90 | 43.89 | 54.91 | 70.84 | 90.81 |
| Operating Profit | 3.99 | 3.99 | 5.99 | 12.99 | 19.99 |
| OPM % | 7.0% | 9.0% | 10.1% | 15.1% | 18.0% |
| Other Income | 0.00 | 0.99 | 0.99 | 1.99 | 1.99 |
| Interest | 1.01 | 2.01 | 3.01 | 4.02 | 4.02 |
| Depreciation | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| Profit before tax | 0.99 | 2.01 | 2.99 | 10.01 | 16.99 |
| Tax % | 25.0% | 28.0% | 31.0% | 25.0% | 30.1% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 1.01 | 1.01 | 2.01 | 7.03 | 12.05 |
| EPS (Rs) | 3.22 | 2.09 | 2.88 | 11.13 | 7.02 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 2.99 | 4.99 | 6.99 | 6.99 | 17.01 |
| Reserves | 1.01 | 2.99 | 5.99 | 12.99 | 61.97 |
| Borrowings | 23.04 | 26.03 | 33.07 | 36.08 | 18.04 |
| Other Liabilities | 18.93 | 15.98 | 17.93 | 22.89 | 19.95 |
| Total Liabilities | 45.97 | 50.99 | 62.98 | 77.95 | 117 |
| Fixed Assets | 12.02 | 15.03 | 19.03 | 19.05 | 20.05 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 5.99 |
| Other Assets | 33.95 | 35.96 | 44.95 | 59.90 | 90.93 |
| Inventories | 13.27 | 14.91 | 18.18 | 23.73 | 29.24 |
| Trade receivables | 13.64 | 14.17 | 16.79 | 24.88 | 48.71 |
| Cash & equivalents | 0.40 | 0.06 | 0.36 | 0.06 | 0.19 |
| Total Assets | 45.97 | 50.99 | 62.98 | 77.95 | 117 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | −1.01 | −1.01 | −1.01 | 2.01 | −19.03 |
| Cash from investing activity | −2.99 | −2.99 | 11.98 | 1.99 | −6.99 |
| Cash from financing activity | 4.01 | 4.01 | −11.01 | −4.01 | 26.03 |
| Net cash flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capex | 2.66 | 3.33 | 0.00 | 0.00 | 2.54 |
| Free cash flow | −3.99 | −3.99 | 10.97 | 3.99 | −21.92 |
| CFO / OP % | −36.0% | −23.0% | −10.0% | 17.1% | −81.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 102 | 107 | 100 | 108 | 161 |
| Inventory days | 141 | 173 | 172 | 157 | 143 |
| Days payable | 186 | 155 | 142 | 117 | 56 |
| Cash conversion cycle | 58 | 125 | 131 | 148 | 247 |
| Working capital days | 16 | 18 | 29 | 37 | 163 |
| ROCE % | — | 12.0% | 14.0% | 26.9% | 28.0% |
For the Mar 2026 quarter, Neochem Bio Solutions reported sales of ₹64.76 Cr, up 38.4% year on year and net profit of ₹7.03 Cr, up 16.8% year on year. The operating margin was 17.0%.
Neochem Bio Solutions' sales for the year to Mar 2026 were ₹111 Cr.
Net profit for the year to Mar 2026 was ₹12.05 Cr. Earnings per share over the same trailing period were ₹7.02.
Neochem Bio Solutions reported borrowings of ₹18.04 Cr at Mar 2026, against cash and equivalents of ₹0.19 Cr.
Cash from operations was −₹19.03 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹21.92 Cr.